E

Emergent Biosolutions
D

EBS

7.72000
USD
-0.12
(-1.53%)
مغلق
حجم التداول
39,371
الربح لكل سهم
2
العائد الربحي
-
P/E
-2
حجم السوق
418,301,916
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    CBOE
    CBOE
    1.900
    (0.91%)
    211.040 USD
    CME
    CME
    0.490
    (0.20%)
    248.850 USD
    G
    GNK
    -0.580
    (-3.93%)
    14.160 USD
    H
    HAL
    -0.745
    (-2.76%)
    26.260 USD
    ICE
    ICE
    1.050
    (0.63%)
    167.880 USD
    NDAQ
    NDAQ
    -1.500
    (-1.82%)
    81.080 USD
    N
    NG
    -0.19500
    (-6.02%)
    3.04500 USD
    O
    OFG
    -0.060
    (-0.14%)
    41.680 USD
    L
    LSE
    -0.32000
    (-6.04%)
    4.98000 USD
    المزيد
الأخبار
المقالات

العنوان: Emergent Biosolutions

القطاع: Healthcare
الصناعة: Drug Manufacturers - Specialty & Generic
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN(R) and other commercial products.